Pregnolia, a femtech startup, has raised CHF 2.2 million in another round of financing. The company has developed a device for measuring cervical stiffness in pregnant women, an important parameter in predicting spontaneous premature births.
The investment is earmarked to evolve its device, originally designed for identifying premature birth risks, into a comprehensive diagnostic system. These funds will also support the company’s strategic entry into the US market, representing a crucial step in advancing maternal healthcare solutions.
Bär & Karrer acted as legal advisor to Pregnolia in this transaction. The team included partner Raphael Annasohn (pictured, M&A) and associates Luana Stämpfli (M&A) as well as Fabian Turtschi (notarial services).